Relevance of targeting GH in the tumor microenvironment: We and others have described a covert action of GH–GHR in cancer, not only in increasing cell proliferation and decreasing tumor cell apoptosis, but also in driving therapy resistance against radiation therapy, chemotherapy, targeted therapy, and immunotherapy [8,10,68]. Here, GHR is linked to cancer.